🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Finally. We figured out the dense deposits in dense deposit disease (DDD). The answer is Apolipoprotein E. You can stain for APOE & make the diagnosis of DDD in >80% cases. Without electron 🔬. DDD was the reason I got into mass spectrometry 17 yrs ago. doi.org/10.1016/j.kint…

Diabetic Nephropathy: Update on Pillars of Therapy Slowing Progression diabetesjournals.org/care/article/4…

"🔍 Renal biopsy in pregnancy: a challenging yet 💥 sometimes crucial procedure. ⚡️Check out the indications, procedure, and potential complications in my latest infographic. 💫Understanding the delicate balance is key for maternal and fetal health. #RenalBiopsy

Updated Review of Membranous Nephropathy ca. 2024 from Indian Journal of Nephrology Orhan Efe Paolo Nikolai So Urmila Anandh Nasim Wiegley, MD, FASN GlomCon #Nephpearls 👉🏼 indianjnephrol.org/an-updated-rev…

✅ It is my IMMENSE PLEASURE to share with you our SEMINAR on systemic #Lupus just published in... The LANCET!!!!! Amazing work driven by Alberta Hoi 👍 LINK: authors.elsevier.com/a/1ixq7V-4XOrME

Systemic lupus erythematosus - ScienceDirect sciencedirect.com/science/articl…

Two recent reviews of #ANCA vasculitis with wonderful graphics, and for the first time I think, #PR3🔹 and #MPO🔸 phenotypes are considered in parallel but SEPARATELY! A new era with individualized treatment is coming for sure! 🔹doi.org/10.1016/s2665-… 🔸doi.org/10.1016/s2665-…

Lipid management in CKD from KDIGO #NephJC #Nephpearls #VisualGraphic by Vamsidhar Veeranki 👉kdigo.org/guidelines/ckd…

Presented at #ERA24: FLOW trial: In patients with type 2 diabetes and chronic kidney disease, weekly semaglutide significantly reduced risks of major kidney events, cardiovascular events, and death from any cause while slowing loss of kidney function. nej.md/44U3slP

💡ACTUALIZACIÓN KDIGO 2024 Clinical Practice Guideline for Antineutrophilic Cytoplasmic Antibody (ANCA)-associated Vasculitis: 🚀kdigo.org/wp-content/upl… 🚀kdigo.org/guidelines/ant…

Complement inhibitors ca. 2024 from Kidney International KDIGO #Nephpearls 👉 pubmed.ncbi.nlm.nih.gov/38844295/

New: Either ACEi or ARB therapy protect against kidney failure in those with advanced CKD. Neither therapy provided a death benefit for those with late-stage CKD: ecs.page.link/SWNAD

Immune checkpoint inhibitor-associated nephritis - treatment standard academic.oup.com/ndt/article-ab…

Ten tips on immunosuppression in primary membranous nephropathy academic.oup.com/ckj/article/17…

Exciting to see this shared! Here's the full paper for anyone interested: frontiersin.org/journals/nephr…

Early steroid withdrawal and kidney transplant outcomes in first-transplant and retransplant recipients doi.org/10.1093/ndt/gf…

IgA Nephropathy (IgAN) ca. 2024 from JASN_News #Nephpearls 📌 Pathogenesis (4 hit hypothesis) 📌 Complement Pathway 📌 Trials 👉🏼 pubmed.ncbi.nlm.nih.gov/37772889/

Point-of-care summary of core HFrEF GDMT safety across CKD stages/ ESKD from Ruey Hu, MD, MPH Kidney in Cardiovascular Disease #Nephpearls #Cardiorenal 👉 gdmt.org/Contest/

🚨NEW MAJOR GUIDELINE!🚨 Managing blood pressure in patients on dialysis One of the first of its kind, this unique & comprehensive guideline makes key recommendations for BP targets, treatment & care strategies. ➡️Download now to discover more: ow.ly/pABq50ViWCB